Anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors in COVID-19
Description
The ongoing pandemic of COVID-19 is intrinsically a systemic inflammatory disorder; hence, those patients suffering an underlying chronic inflammatory disease such as diabetes mellitus are at high risk of severe complications. Preventing or
